Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

PRP helps skin heal, possibly through special cells called telocytes.

Better hair loss models needed for research.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Finasteride affects SRD5A2 gene pattern, possibly causing lasting side effects.

Improper diet, lifestyle, and stress are major causes of hair fall.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Lower SHBG levels may increase the risk of PCOS.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Skin aging reflects overall body aging and can indicate internal health conditions.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.